K. Cohen

发表

CMS-HCC Risk Score Accuracy Improves Clinical Outcomes among Medicare Advantage Enrollees

K. Cohen, M. AlokeK, 2017 .

Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity

David M. Liebovitz, D. Vojta, L. Aronne, 2021, Journal of medical virology.

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

N. Sheils, K. Cohen, Nazmul Islam, 2022, Nature Communications.

High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients With COVID-19 Infection

K. Lakshminarayan, K. Cohen, M. McCullough-Hicks, 2022, Stroke.

Efficacy and Safety of Mechanical IVC Filtration for Preventing Pulmonary Embolism in High-Risk Orthopedic Patients Undergoing Total Hip or Knee Arthroplasty.

Mikin V Patel, H. Luu, O. Ahmed, 2021, The Journal of arthroplasty.

Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms

David M. Liebovitz, N. Sherwood, D. Boulware, 2022, Open forum infectious diseases.

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

David M. Liebovitz, N. Sherwood, D. Boulware, 2022, The New England journal of medicine.

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

Kevin N. Heath, M. Lipsitch, K. Cohen, 2021, BMJ.

Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study

Kevin N. Heath, M. Lipsitch, K. Cohen, 2022, BMJ.

Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up

David M. Liebovitz, D. Boulware, D. Odde, 2022, medRxiv.

SARS-CoV-2 infection and risk of clinical sequelae during the post-acute phase: a retrospective cohort study

M. Lipsitch, Y. Guo, K. Cohen, 2021, medRxiv.

Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study

D. Cook, K. Cohen, David Anderson, 2021, BMJ Open.

Does the elevated thrombosis risk of males relative to females help account for the excess male mortality observed in Covid-19? An observational study

K. Cohen, D. Cook, D. Anderson, 2021, medRxiv.

Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial

David M. Liebovitz, N. Sherwood, D. Boulware, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

David M. Liebovitz, N. Sherwood, M. Rose, 2023, The Lancet Infectious Diseases.

Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial

David M. Liebovitz, Tejas Mehta, D. Boulware, 2023, medRxiv.